April 25, 2022 by Bryan Gildenberg
Bryan Gildenberg is senior vice president of commerce at the Omnicom Commerce Group
April 25, 2022, Opinion
Collectively, we have spent much of the last two years solving immediate and short-term challenges in both the supply chain and the demand chain. Recently much has been made of the metaverse and the investments required to succeed in an important but far away future engagement platform. What seems to have gotten squeezed in this
April 25, 2022 by Dave Wendland
Dave Wendland is vice president of strategic relations at Hamacher Resource Group Inc. (HRG).
April 25, 2022, Opinion
As customer expectations transform, supply chain issues remain, cost pressures rise and workforce challenges linger, retail drug stores must continue their rapid change and transformation. The aftermath of the COVID-19 pandemic has greatly accelerated this necessary evolution. During this time of reinvention across the industry, I’m reminded of the old real estate adage, “Location, location,
April 25, 2022 by Tom Furphy
Amazon Pharmacy, Tom Furphy is chief executive officer and managing director of Consumer Equity Partners.
April 25, 2022, Opinion
Chain drug stores are facing unprecedented challenges on several fronts today, not the least of which is the need to grow merchandise sales. The continuing trend of mail order prescriptions takes foot traffic from the stores. New nontraditional offerings such as Amazon Pharmacy and Cost Plus Pharmacy, Mark Cuban’s new venture, further threaten to erode
April 25, 2022 by Wendy Liebmann
Wendy Liebmann
April 25, 2022, Opinion
Six months into the pandemic, in the first of many How America Shops research studies we conducted, 52% of a national sample of shoppers said they were proud of how they were managing. As the pandemic raged on, decimated populations and transformed everyday retail, these Americans were figuring out how to cope, and were proud
April 25, 2022 by Jeffrey Woldt
Jeffrey Woldt editor-in-chief Chain Drug Review
April 25, 2022, Opinion
In the last issue of Chain Drug Review, this space was devoted to an assessment of brick-and-mortar drug stores’ future in the wake of market dynamics forever changed by the COVID pandemic, the pressing need to revamp health care delivery in America, and shoppers’ enthusiastic embrace of digital technology. Chain drug retailers were praised for
April 25, 2022 by David Pinto
David Pinto
April 25, 2022, Opinion
Among the assignments the editorial staff at Racher Press, publisher of MMR and Chain Drug Review, carries out with alacrity and a degree of professionalism is that of bringing buyers and sellers together, of greasing the table where buyers and sellers can meet and move their businesses forward. So it was on a chilly Tuesday
April 21, 2022 by Chain Drug Review
AmerisourceBergen, George Rafferty, Gina Clark
April 25, 2022, Leading Headlines
CONSHOHOCKEN, Pa. — Don’t fear that asking others for help makes you appear weaker, don’t be afraid to let others help you — and trust your instincts. This was the advice that Gina Clark, executive vice president and chief communication and administration officer at AmerisourceBergen (AB), said she would give to her younger self. Gina’s